Contact information
liberty.cantrell@paediatrics.ox.ac.uk
https://orcid.org/0000-0001-5413-7641
Oxford Vaccine Group, CCVTM, Churchill Rd, Headington, Oxford, OX3 7LE
Research groups
Liberty Cantrell
MSc BSc
Medical Statistician & DPhil Student
Liberty joined the Oxford Vaccine Group in 2021 after graduating from the University of Nottingham with a BSc in Mathematics and an MSc in Statistics. Since joining the team she has worked across a variety of research areas including COVID-19, pertussis and group B streptococcus (GBS).
Liberty started her DPhil in 2023 studying correlates of protection for vaccines against GBS. During this work, she is investigating antibody levels associated with a reduced risk of infant disease using case-control data from countries across Europe and Africa. She has also been conducting simulation studies to investigate the impact of the choice of analysis method on the results.
Her research interests include vaccinations during pregnancy and correlates of protection.
Recent publications
-
Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14 805 care homes in England.
Chen S. et al, (2025), BMJ Public Health, 3
-
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.
Nakabembe E. et al, (2025), Lancet Glob Health, 13, e81 - e97
-
Understanding COVID-19 testing behaviour in England through a sociodemographic lens : a population based study
Bajaj S. et al, (2024), The Lancet Digital Health
-
COVID-19 mass testing in adult social care in England
Chen S. et al, (2024)
-
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53